The Latest
-
Industry Analysts Just Upgraded Their Immunomedics, Inc. (NASDAQ:IMMU) Revenue Forecasts By 16%
-
Why I Cashed Out of the Covid-19 Rally
-
Former Trucking Company Co-Owner Gets 15 Months For Wire Fraud
-
Nightmare at Sea Ends In Death for Some Cruise Ship Workers